nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—Congestive cardiomyopathy—Riluzole—amyotrophic lateral sclerosis	0.0902	0.0902	CcSEcCtD
Ifosfamide—Alveolitis allergic—Riluzole—amyotrophic lateral sclerosis	0.0363	0.0363	CcSEcCtD
Ifosfamide—Major depression—Riluzole—amyotrophic lateral sclerosis	0.0351	0.0351	CcSEcCtD
Ifosfamide—Methaemoglobinaemia—Riluzole—amyotrophic lateral sclerosis	0.0322	0.0322	CcSEcCtD
Ifosfamide—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.0265	0.0265	CcSEcCtD
Ifosfamide—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.0219	0.0219	CcSEcCtD
Ifosfamide—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.0188	0.0188	CcSEcCtD
Ifosfamide—Polyp—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0156	CcSEcCtD
Ifosfamide—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0149	CcSEcCtD
Ifosfamide—Cyst—Riluzole—amyotrophic lateral sclerosis	0.0142	0.0142	CcSEcCtD
Ifosfamide—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0139	CcSEcCtD
Ifosfamide—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0136	CcSEcCtD
Ifosfamide—Ileus—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0134	CcSEcCtD
Ifosfamide—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0134	CcSEcCtD
Ifosfamide—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0134	CcSEcCtD
Ifosfamide—Mania—Riluzole—amyotrophic lateral sclerosis	0.013	0.013	CcSEcCtD
Ifosfamide—Stupor—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0127	CcSEcCtD
Ifosfamide—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0126	CcSEcCtD
Ifosfamide—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0124	CcSEcCtD
Ifosfamide—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0124	CcSEcCtD
Ifosfamide—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0115	CcSEcCtD
Ifosfamide—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0114	CcSEcCtD
Ifosfamide—Delirium—Riluzole—amyotrophic lateral sclerosis	0.011	0.011	CcSEcCtD
Ifosfamide—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Ifosfamide—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0105	CcSEcCtD
Ifosfamide—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.01	0.01	CcSEcCtD
Ifosfamide—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.0097	0.0097	CcSEcCtD
Ifosfamide—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00964	0.00964	CcSEcCtD
Ifosfamide—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00947	0.00947	CcSEcCtD
Ifosfamide—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00947	0.00947	CcSEcCtD
Ifosfamide—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00914	0.00914	CcSEcCtD
Ifosfamide—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00914	0.00914	CcSEcCtD
Ifosfamide—Coma—Riluzole—amyotrophic lateral sclerosis	0.00865	0.00865	CcSEcCtD
Ifosfamide—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00856	0.00856	CcSEcCtD
Ifosfamide—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00842	0.00842	CcSEcCtD
Ifosfamide—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00821	0.00821	CcSEcCtD
Ifosfamide—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00798	0.00798	CcSEcCtD
Ifosfamide—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00786	0.00786	CcSEcCtD
Ifosfamide—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00768	0.00768	CcSEcCtD
Ifosfamide—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00731	0.00731	CcSEcCtD
Ifosfamide—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00725	0.00725	CcSEcCtD
Ifosfamide—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00704	0.00704	CcSEcCtD
Ifosfamide—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00687	0.00687	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00687	0.00687	CcSEcCtD
Ifosfamide—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00671	0.00671	CcSEcCtD
Ifosfamide—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00653	0.00653	CcSEcCtD
Ifosfamide—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00653	0.00653	CcSEcCtD
Ifosfamide—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00625	0.00625	CcSEcCtD
Ifosfamide—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00621	0.00621	CcSEcCtD
Ifosfamide—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00582	0.00582	CcSEcCtD
Ifosfamide—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00578	0.00578	CcSEcCtD
Ifosfamide—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00564	0.00564	CcSEcCtD
Ifosfamide—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00555	0.00555	CcSEcCtD
Ifosfamide—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00549	CcSEcCtD
Ifosfamide—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00533	0.00533	CcSEcCtD
Ifosfamide—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00529	0.00529	CcSEcCtD
Ifosfamide—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00529	0.00529	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00522	0.00522	CcSEcCtD
Ifosfamide—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00519	0.00519	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00519	0.00519	CcSEcCtD
Ifosfamide—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00516	0.00516	CcSEcCtD
Ifosfamide—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00505	0.00505	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00501	0.00501	CcSEcCtD
Ifosfamide—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00494	CcSEcCtD
Ifosfamide—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00484	CcSEcCtD
Ifosfamide—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00478	0.00478	CcSEcCtD
Ifosfamide—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00475	0.00475	CcSEcCtD
Ifosfamide—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00475	0.00475	CcSEcCtD
Ifosfamide—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00473	CcSEcCtD
Ifosfamide—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00469	CcSEcCtD
Ifosfamide—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00467	CcSEcCtD
Ifosfamide—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00466	CcSEcCtD
Ifosfamide—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00449	CcSEcCtD
Ifosfamide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00444	0.00444	CcSEcCtD
Ifosfamide—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00441	CcSEcCtD
Ifosfamide—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00431	0.00431	CcSEcCtD
Ifosfamide—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00429	CcSEcCtD
Ifosfamide—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00428	CcSEcCtD
Ifosfamide—Chills—Riluzole—amyotrophic lateral sclerosis	0.00426	0.00426	CcSEcCtD
Ifosfamide—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00425	0.00425	CcSEcCtD
Ifosfamide—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0042	0.0042	CcSEcCtD
Ifosfamide—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00416	CcSEcCtD
Ifosfamide—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00414	0.00414	CcSEcCtD
Ifosfamide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00384	CcSEcCtD
Ifosfamide—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00382	CcSEcCtD
Ifosfamide—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0038	0.0038	CcSEcCtD
Ifosfamide—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00378	CcSEcCtD
Ifosfamide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00373	CcSEcCtD
Ifosfamide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00372	0.00372	CcSEcCtD
Ifosfamide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0037	0.0037	CcSEcCtD
Ifosfamide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00366	CcSEcCtD
Ifosfamide—Cough—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00361	CcSEcCtD
Ifosfamide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00358	0.00358	CcSEcCtD
Ifosfamide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00357	CcSEcCtD
Ifosfamide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00352	CcSEcCtD
Ifosfamide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00352	CcSEcCtD
Ifosfamide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00352	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0035	0.0035	CcSEcCtD
Ifosfamide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00348	CcSEcCtD
Ifosfamide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0034	CcSEcCtD
Ifosfamide—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00338	CcSEcCtD
Ifosfamide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00338	CcSEcCtD
Ifosfamide—Infection—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00335	CcSEcCtD
Ifosfamide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00331	CcSEcCtD
Ifosfamide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00331	CcSEcCtD
Ifosfamide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00328	CcSEcCtD
Ifosfamide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00326	0.00326	CcSEcCtD
Ifosfamide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00322	CcSEcCtD
Ifosfamide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00316	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00308	CcSEcCtD
Ifosfamide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00303	CcSEcCtD
Ifosfamide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00301	CcSEcCtD
Ifosfamide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.003	0.003	CcSEcCtD
Ifosfamide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00294	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00292	CcSEcCtD
Ifosfamide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00291	CcSEcCtD
Ifosfamide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00289	CcSEcCtD
Ifosfamide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00289	CcSEcCtD
Ifosfamide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00278	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00276	CcSEcCtD
Ifosfamide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00268	CcSEcCtD
Ifosfamide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00267	CcSEcCtD
Ifosfamide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00267	CcSEcCtD
Ifosfamide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00249	CcSEcCtD
Ifosfamide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00242	CcSEcCtD
Ifosfamide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00239	CcSEcCtD
Ifosfamide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00231	CcSEcCtD
Ifosfamide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00223	CcSEcCtD
Ifosfamide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00215	CcSEcCtD
Ifosfamide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00213	CcSEcCtD
Ifosfamide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00213	CcSEcCtD
Ifosfamide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00201	CcSEcCtD
